APA (7th ed.) Citation

Halalsheh, H., McCarville, M. B., Neel, M., Reynolds, M., Cox, M. C., & Pappo, A. S. (2018). Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma. Pediatric blood & cancer, 65(10), e27271-n/a. https://doi.org/10.1002/pbc.27271

Chicago Style (17th ed.) Citation

Halalsheh, Hadeel, Mary Beth McCarville, Michael Neel, Mark Reynolds, Michael C. Cox, and Alberto S. Pappo. "Dramatic Bone Remodeling Following Larotrectinib Administration for Bone Metastasis in a Patient with TRK Fusion Congenital Mesoblastic Nephroma." Pediatric Blood & Cancer 65, no. 10 (2018): e27271-n/a. https://doi.org/10.1002/pbc.27271.

MLA (9th ed.) Citation

Halalsheh, Hadeel, et al. "Dramatic Bone Remodeling Following Larotrectinib Administration for Bone Metastasis in a Patient with TRK Fusion Congenital Mesoblastic Nephroma." Pediatric Blood & Cancer, vol. 65, no. 10, 2018, pp. e27271-n/a, https://doi.org/10.1002/pbc.27271.